ArticleLancet (London, England)2014

Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.

Vincenzo Libri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.